Artelo Biosciences Raises $9.5M for Solana-Based Digital Asset Reserve Strategy
Biopharmaceutical firm Artelo Biosciences has secured $9.475 million through a private placement aimed at establishing a digital asset reserve strategy utilizing Solana (SOL). This initiative positions Artelo as the first publicly-traded pharmaceutical company to adopt a digital asset reserve strategy… Read More »Artelo Biosciences Raises $9.5M for Solana-Based Digital Asset Reserve Strategy